tiprankstipranks
Icu Medical (ICUI)
NASDAQ:ICUI
US Market
ICUI
ICU Medical
RESEARCH TOOLSreports
Want to see ICUI full AI Analyst Report?

ICU Medical (ICUI) Ratios

206 Followers

ICU Medical Ratios

ICUI's free cash flow for Q1 2026 was $0.33. For the 2026 fiscal year, ICUI's free cash flow was decreased by $ and operating cash flow was $0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.30 2.36 2.59 2.53 2.50
Quick Ratio
 1.13 1.13 1.54 1.06 1.09
Cash Ratio
 0.56 0.62 0.55 0.53 0.42
Solvency Ratio
 0.13 0.11 -0.05 0.09 0.07
Operating Cash Flow Ratio
 0.32 0.36 0.37 0.34 -0.13
Short-Term Operating Cash Flow Coverage
 4.90 5.19 4.00 3.26 -2.09
Net Current Asset Value
$ -712.85M$ -749.24M$ -796.71M$ -1.03B$ -1.19B
Leverage Ratios
Debt-to-Assets Ratio
 0.33 0.34 0.39 0.39 0.38
Debt-to-Equity Ratio
 0.64 0.66 0.84 0.80 0.83
Debt-to-Capital Ratio
 0.39 0.40 0.46 0.45 0.45
Long-Term Debt-to-Capital Ratio
 0.37 0.38 0.44 0.43 0.44
Financial Leverage Ratio
 1.90 1.91 2.14 2.06 2.16
Debt Service Coverage Ratio
 4.11 2.31 -0.06 1.96 2.31
Interest Coverage Ratio
 1.57 1.01 0.40 0.22 -0.61
Debt to Market Cap
 0.44 0.38 0.42 0.68 0.44
Interest Debt Per Share
 56.23 60.78 71.68 74.99 75.63
Net Debt to EBITDA
 3.35 3.32 31.03 5.73 7.96
Profitability Margins
Gross Profit Margin
36.36%36.76%34.62%32.75%30.60%
EBIT Margin
5.08%4.87%1.70%1.08%-1.91%
EBITDA Margin
14.58%14.64%1.80%11.21%8.40%
Operating Profit Margin
3.72%4.80%1.80%1.01%-1.88%
Pretax Profit Margin
0.44%0.14%-2.77%-3.47%-5.02%
Net Profit Margin
2.15%0.03%-4.94%-1.31%-3.26%
Continuous Operations Profit Margin
2.15%0.03%-4.94%-1.31%-3.26%
Net Income Per EBT
488.15%23.10%178.28%37.87%64.93%
EBT Per EBIT
11.83%2.96%-153.64%-343.04%266.70%
Return on Assets (ROA)
1.15%0.02%-2.80%-0.68%-1.65%
Return on Equity (ROE)
2.19%0.03%-5.99%-1.40%-3.55%
Return on Capital Employed (ROCE)
2.29%3.01%1.18%0.59%-1.07%
Return on Invested Capital (ROIC)
2.27%0.69%1.16%0.22%-0.68%
Return on Tangible Assets
2.40%0.04%-5.80%-1.46%-3.57%
Earnings Yield
1.58%0.02%-3.11%-1.23%-1.98%
Efficiency Ratios
Receivables Turnover
 10.72 12.35 11.75 12.40 9.23
Payables Turnover
 7.89 9.14 10.52 10.13 7.33
Inventory Turnover
 2.27 2.29 2.66 2.14 2.27
Fixed Asset Turnover
 4.29 4.40 4.77 3.30 3.20
Asset Turnover
 0.54 0.55 0.57 0.52 0.50
Working Capital Turnover Ratio
 3.20 2.85 2.93 3.05 2.91
Cash Conversion Cycle
 148.82 148.98 133.40 163.81 150.28
Days of Sales Outstanding
 34.03 29.55 31.06 29.43 39.53
Days of Inventory Outstanding
 161.06 159.38 137.04 170.42 160.56
Days of Payables Outstanding
 46.27 39.95 34.69 36.04 49.81
Operating Cycle
 195.10 188.93 168.10 199.85 200.09
Cash Flow Ratios
Operating Cash Flow Per Share
 6.76 7.30 8.37 6.90 -2.60
Free Cash Flow Per Share
 3.25 3.73 5.11 3.01 -6.76
CapEx Per Share
 3.51 3.57 3.25 3.89 4.16
Free Cash Flow to Operating Cash Flow
 0.48 0.51 0.61 0.44 2.60
Dividend Paid and CapEx Coverage Ratio
 1.92 2.04 2.57 1.77 -0.63
Capital Expenditure Coverage Ratio
 1.92 2.04 2.57 1.77 -0.63
Operating Cash Flow Coverage Ratio
 0.12 0.13 0.12 0.10 -0.04
Operating Cash Flow to Sales Ratio
 0.08 0.08 0.09 0.07 -0.03
Free Cash Flow Yield
2.71%2.61%3.29%3.02%-4.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 63.44 4.80K -32.16 -81.03 -50.60
Price-to-Sales (P/S) Ratio
 1.38 1.58 1.59 1.06 1.65
Price-to-Book (P/B) Ratio
 1.39 1.66 1.93 1.13 1.80
Price-to-Free Cash Flow (P/FCF) Ratio
 36.91 38.29 30.36 33.13 -23.28
Price-to-Operating Cash Flow Ratio
 17.56 19.55 18.55 14.46 -60.50
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -47.73 -0.11 1.34 0.31
Price-to-Fair Value
 1.39 1.66 1.93 1.13 1.80
Enterprise Value Multiple
 12.78 14.09 119.11 15.22 27.59
Enterprise Value
 4.02B 4.60B 5.12B 3.85B 5.28B
EV to EBITDA
 12.78 14.09 119.11 15.22 27.59
EV to Sales
 1.86 2.06 2.15 1.71 2.32
EV to Free Cash Flow
 50.00 50.10 41.05 53.11 -32.73
EV to Operating Cash Flow
 24.01 25.58 25.08 23.18 -85.05
Tangible Book Value Per Share
 1.11 -0.39 -8.54 -9.12 -14.33
Shareholders’ Equity Per Share
 85.28 86.19 80.58 88.14 87.56
Tax and Other Ratios
Effective Tax Rate
 -3.88 0.77 -0.78 0.62 0.35
Revenue Per Share
 87.08 90.50 97.67 93.77 95.53
Net Income Per Share
 1.87 0.03 -4.83 -1.23 -3.11
Tax Burden
 4.88 0.23 1.78 0.38 0.65
Interest Burden
 0.09 0.03 -1.63 -3.21 2.62
Research & Development to Revenue
 0.04 0.04 0.04 0.04 0.04
SG&A to Revenue
 0.29 0.28 0.27 0.00 0.00
Stock-Based Compensation to Revenue
 0.02 0.03 0.02 0.02 0.02
Income Quality
 3.61 245.69 -1.73 -5.60 0.84
Currency in USD